UBE2L6 and sarcoidosis: Serum from patients with sarcoidosis significantly (p < 0.01) induced the expression of FCGR1B, GBP1, IFIT2, IRF7, MYD88, SERPING1, STAT1, UBE2L6, and MX1 compared to serum from patients with TB (Supplementary Figs. 1B–J).